✦ LIBER ✦

Management of Relapsing-Remitting Multiple Sclerosis

✍ Scribed by Katherine A. Lyseng-Williamson, Greg L. Plosker

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Natalizumab: A Review of Its Use in the

✍ Paul L. McCormack 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 486 KB

Management of relapsing–remitting multip

✍ Correale, Jorge; Abad, Patricio; Alvarenga, Regina; Alves-Leon, Soniza; Armas, E 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 677 KB

Managing side effects of interferon-beta

✍ Frederick E. Munschauer III; Revere Philip Kinkel 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 808 KB

PND35 Belgian Cost-Utility Analysis of G

✍ S. Drieskens; K. Moeremans 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Cyclophosphamide in relapsing remitting

✍ F. D'Andrea; C. D'Aurizio; C. Marini; M. Prencipe 📂 Article 📅 1990 🏛 Springer Milan 🌐 English ⚖ 321 KB

Interferons in relapsing remitting multi

✍ Douglas S Goodin 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 52 KB